These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 16273366

  • 21. Reducing the risk of distant metastases: a better end point in adjuvant aromatase inhibitor breast cancer trials?
    Tang SC.
    Cancer Invest; 2008 Jun; 26(5):481-90. PubMed ID: 18568770
    [Abstract] [Full Text] [Related]

  • 22. Extended breast cancer treatment with an aromatase inhibitor (Letrozole) after tamoxifen: why, who and how long?
    Kaufmann M, Rody A.
    Eur J Obstet Gynecol Reprod Biol; 2006 Jun 01; 126(2):146-54. PubMed ID: 16621229
    [Abstract] [Full Text] [Related]

  • 23. Preventing relapse beyond 5 years: the MA.17 extended adjuvant trial.
    Goss PE.
    Semin Oncol; 2006 Apr 01; 33(2 Suppl 7):S8-12. PubMed ID: 16730271
    [Abstract] [Full Text] [Related]

  • 24. Beyond tamoxifen: extended and late extended endocrine therapy in postmenopausal early breast cancer.
    Dodwell D, Williamson D.
    Cancer Treat Rev; 2008 Apr 01; 34(2):137-44. PubMed ID: 18006236
    [Abstract] [Full Text] [Related]

  • 25. Refining the postmenopausal breast cancer treatment paradigm: the FACE trial.
    Monnier A.
    Expert Rev Anticancer Ther; 2006 Oct 01; 6(10):1355-9. PubMed ID: 17069521
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Early recurrence risk: aromatase inhibitors versus tamoxifen.
    Bria E, Carlini P, Cuppone F, Vaccaro V, Milella M, Cognetti F.
    Expert Rev Anticancer Ther; 2010 Aug 01; 10(8):1239-53. PubMed ID: 20735310
    [Abstract] [Full Text] [Related]

  • 28. Extending the benefits of adjuvant therapy in early HR+ breast cancer.
    Goss PE.
    Breast Cancer Res Treat; 2008 Dec 01; 112 Suppl 1():45-52. PubMed ID: 18785006
    [Abstract] [Full Text] [Related]

  • 29. Risk reduction of distant metastasis in hormone-sensitive postmenopausal breast cancer.
    Toi M, Yamashiro H, Tsuji W.
    Breast Cancer; 2009 Dec 01; 16(3):207-18. PubMed ID: 19259765
    [Abstract] [Full Text] [Related]

  • 30. Adjuvant and extended adjuvant use of aromatase inhibitors: reducing the risk of recurrence and distant metastasis.
    Gligorov J, Pritchard K, Goss P.
    Breast; 2007 Dec 01; 16 Suppl 3():S1-9. PubMed ID: 18061455
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Letrozole as adjuvant endocrine therapy in postmenopausal women with breast cancer.
    Koeberle D, Thuerlimann B.
    Expert Rev Anticancer Ther; 2006 Jan 01; 6(1):5-10. PubMed ID: 16375638
    [Abstract] [Full Text] [Related]

  • 33. Cardiovascular safety profiles of aromatase inhibitors : a comparative review.
    Nabholtz JM, Gligorov J.
    Drug Saf; 2006 Jan 01; 29(9):785-801. PubMed ID: 16944964
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Optimising adjuvant endocrine treatment of breast cancer with aromatase inhibitors.
    Fentiman IS.
    Int J Clin Pract; 2006 Jun 01; 60(6):689-93. PubMed ID: 16805754
    [Abstract] [Full Text] [Related]

  • 36. Current topics and perspectives on the use of aromatase inhibitors in the treatment of breast cancer.
    Iwase H.
    Breast Cancer; 2008 Jun 01; 15(4):278-90. PubMed ID: 18810576
    [Abstract] [Full Text] [Related]

  • 37. Safely promoting breast-conserving surgery and preventing early relapses with an aromatase inhibitor.
    Markopoulos C.
    Surg Oncol; 2008 Aug 01; 17(2):113-28. PubMed ID: 18178077
    [Abstract] [Full Text] [Related]

  • 38. Clinical practice decisions in endocrine therapy.
    Untch M, Thomssen C.
    Cancer Invest; 2010 Aug 01; 28 Suppl 1():4-13. PubMed ID: 20653403
    [Abstract] [Full Text] [Related]

  • 39. Clinical differences among the aromatase inhibitors.
    Ligibel JA, Winer EP.
    Clin Cancer Res; 2003 Jan 01; 9(1 Pt 2):473S-9S. PubMed ID: 12538503
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.